Department of Surgery and Transplantation, University of Zurich, Zurich, Switzerland.
Wyss Zurich Translational Center, ETH Zurich and University of Zurich, Zurich, Switzerland.
Ann Surg. 2024 Nov 1;280(5):887-895. doi: 10.1097/SLA.0000000000006462. Epub 2024 Jul 30.
To assess the impact of normothermic machine perfusion (NMP) on patients, medical teams, and costs by gathering global insights and exploring current limitations.
NMP for ex situ liver graft perfusion is gaining increasing attention for its capability to extend graft preservation. It has the potential to transform liver transplantation (LT) from an urgent to a purely elective procedure, which could revolutionize LT logistics, reduce burden on patients and health care providers, and decrease costs.
A 31-item survey was sent to international transplant directors to gather their NMP experiences and vision. In addition, we performed a systematic review on cost-analysis in LT and assessed studies on cost-benefit in converting urgent-to-elective procedures. We compared the costs of available NMPs and conducted a sensitivity analysis of NMP's cost benefits.
Of 120 transplant programs contacted, 64 (53%) responded, spanning North America (31%), Europe (42%), Asia (22%), and South America (5%). Of the total, 60% had adopted NMP, with larger centers (>100 transplants/year) in North America and Europe more likely to use it. The main NMP systems were OrganOx-metra (39%), XVIVO (36%), and TransMedics-OCS (15%). Despite NMP adoption, 41% of centers still perform >50% of LTs at nights/weekends. Centers recognized NMP's benefits, including improved work satisfaction and patient outcomes, but faced challenges like high costs and machine complexity. 16% would invest $100,000 to 500'000, 33% would invest $50,000 to 100'000, 38% would invest $10,000 to 50'000, and 14% would invest <$10,000 in NMP. These results were strengthened by a cost analysis for NMP in emergency-to-elective LT transition. Accordingly, while liver perfusions with disposables up to $10,000 resulted in overall positive net balances, this effect was lost when disposables' cost amounted to >$40,000/organ.
The adoption of NMP is hindered by high costs and operational complexity. Making LT elective through NMP could reduce costs and improve outcomes, but overcoming barriers requires national reimbursements and simplified, automated NMP systems for multiday preservation.
通过收集全球见解并探讨当前局限性,评估常温机器灌注(NMP)对患者、医疗团队和成本的影响。
离体肝脏供体的 NMP 因其具有延长供体保存的能力而受到越来越多的关注。它有可能将肝移植(LT)从紧急手术转变为纯粹的择期手术,从而彻底改变 LT 的物流,减轻患者和医疗保健提供者的负担,并降低成本。
我们向国际移植主任发送了一份包含 31 个项目的调查问卷,以收集他们在 NMP 方面的经验和设想。此外,我们对 LT 的成本分析进行了系统评价,并评估了将紧急手术转为择期手术的成本效益研究。我们比较了可用 NMP 的成本,并对 NMP 的成本效益进行了敏感性分析。
在联系的 120 个移植项目中,有 64 个(53%)做出了回应,涵盖了北美(31%)、欧洲(42%)、亚洲(22%)和南美(5%)。在总数中,有 60%的中心采用了 NMP,北美和欧洲较大的中心(>100 例/年)更有可能使用它。主要的 NMP 系统是 OrganOx-metra(39%)、XVIVO(36%)和 TransMedics-OCS(15%)。尽管采用了 NMP,但仍有 41%的中心在夜间/周末进行超过 50%的 LT。中心认识到 NMP 的益处,包括提高工作满意度和患者预后,但面临着高成本和机器复杂性等挑战。16%的中心愿意投资 10 万至 50 万美元,33%的中心愿意投资 5 万至 10 万美元,38%的中心愿意投资 1 万至 5 万美元,14%的中心愿意投资 1 万美元以下用于 NMP。这些结果通过 NMP 在急诊转为择期 LT 过渡中的成本分析得到了加强。因此,尽管使用一次性用品进行肝脏灌注的总净余额为 10000 美元,但当一次性用品的成本达到 40000 美元/器官时,这种效果就会丧失。
NMP 的采用受到高成本和运营复杂性的阻碍。通过 NMP 将 LT 变为择期手术可以降低成本并改善预后,但要克服这些障碍,需要国家报销和简化、自动化的 NMP 系统来进行多天的保存。